AFF1 and acute lymphoblastic leukemia: More recently, Jim Mulloy et al. demonstrated that transplantation of human CD34+ HSPC retrovirally expressing a human–mouse chimeric KMT2A-Aff1 fusion developed pro-B-ALL after a latency of 100–250 days.